[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

LV11026B - A pharmaceutical composition for lowering the blood pressure and a process for the preparation thereof - Google Patents

A pharmaceutical composition for lowering the blood pressure and a process for the preparation thereof Download PDF

Info

Publication number
LV11026B
LV11026B LVP-95-225A LV950225A LV11026B LV 11026 B LV11026 B LV 11026B LV 950225 A LV950225 A LV 950225A LV 11026 B LV11026 B LV 11026B
Authority
LV
Latvia
Prior art keywords
nifedipine
mass
solution
weight
ethyl oleate
Prior art date
Application number
LVP-95-225A
Other languages
English (en)
Latvian (lv)
Other versions
LV11026A (lv
Inventor
Nagy Margit
Farsang Csaba
Fedina Lidia
Szemeredi Katalin
Szenasi Gabor
Egri Janos
Mosonyi Antal
Barta Borbala
Teth Gizella
Nyaradi Ibolya
Girenyi Frigyes
Orr Zsuzsa
Fleris Geza
Original Assignee
Egis Gyegyszergyar Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyegyszergyar Rt filed Critical Egis Gyegyszergyar Rt
Publication of LV11026A publication Critical patent/LV11026A/xx
Publication of LV11026B publication Critical patent/LV11026B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LVP-95-225A 1994-07-26 1995-07-25 A pharmaceutical composition for lowering the blood pressure and a process for the preparation thereof LV11026B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9402193A HU214582B (hu) 1994-07-26 1994-07-26 Porlasztható, vérnyomáscsökkentő hatású gyógyszerkészítmény és eljárás előállítására

Publications (2)

Publication Number Publication Date
LV11026A LV11026A (lv) 1996-02-20
LV11026B true LV11026B (en) 1996-04-20

Family

ID=10985460

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-95-225A LV11026B (en) 1994-07-26 1995-07-25 A pharmaceutical composition for lowering the blood pressure and a process for the preparation thereof

Country Status (18)

Country Link
JP (1) JPH08169829A (et)
AT (1) AT402690B (et)
AU (1) AU699386B2 (et)
BE (1) BE1011413A4 (et)
CZ (1) CZ286399B6 (et)
DE (1) DE19527140A1 (et)
EE (1) EE9500029A (et)
FR (1) FR2722988B1 (et)
GB (1) GB2291593B (et)
HR (1) HRP950374A2 (et)
HU (1) HU214582B (et)
IT (1) IT1277348B1 (et)
LT (1) LT4042B (et)
LV (1) LV11026B (et)
PL (1) PL181069B1 (et)
SK (1) SK280463B6 (et)
UA (1) UA39880C2 (et)
YU (1) YU50795A (et)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
JP2001517689A (ja) * 1997-10-01 2001-10-09 フレミントン ファーマシューティカル コーポレイション 極性または非極性の、バッカルスプレーまたはカプセル
EP2767163A1 (en) * 2005-02-17 2014-08-20 Abbott Laboratories Transmucosal administration of drug compositions for treating and preventing disorders in animals
DE102006027794A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antihypertonie-Kombinationswafer
FR2906140B1 (fr) * 2006-09-22 2008-12-05 Philippe Perovitch Forme galenique pour l'administration par voie trans-muqueuse de principes actifs

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
EP0175671A1 (de) 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
EP0240484B1 (de) * 1986-03-10 1992-01-15 Kurt Dr. Burghart Pharmazeutische Zubereitung sowie Verfahren zur Herstellung derselben
ES2042527T3 (es) * 1986-11-14 1993-12-16 Theratech Inc Un metodo para preparar una composicion farmaceutica aumentadora de la penetracion para la aplicacion topica.
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
JPS63170316A (ja) * 1986-12-30 1988-07-14 Fujimoto Seiyaku Kk ニフエジピン経皮吸収外用製剤
DE3714402A1 (de) * 1987-04-30 1988-11-10 Kali Chemie Pharma Gmbh Arzneimittelformulierung
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
AT391269B (de) * 1988-12-30 1990-09-10 Burghart Kurt Pharmazeutische zubereitung
US5298258A (en) * 1989-12-28 1994-03-29 Nitto Denko Corporation Acrylic oily gel bioadhesive material and acrylic oily gel preparation
HU205249B (en) * 1990-11-09 1992-04-28 Egyt Gyogyszervegyeszeti Gyar Process for producing suspensive aerosole composition

Also Published As

Publication number Publication date
CZ181195A3 (en) 1996-02-14
JPH08169829A (ja) 1996-07-02
EE9500029A (et) 1996-02-15
PL181069B1 (pl) 2001-05-31
HU9402193D0 (en) 1994-09-28
ITMI951621A1 (it) 1997-01-26
CZ286399B6 (en) 2000-04-12
PL309757A1 (en) 1996-02-05
UA39880C2 (uk) 2001-07-16
HUT75457A (en) 1997-05-28
AU699386B2 (en) 1998-12-03
SK92295A3 (en) 1996-05-08
LT4042B (en) 1996-09-25
FR2722988B1 (fr) 1999-10-08
ATA121495A (de) 1996-12-15
SK280463B6 (sk) 2000-02-14
GB2291593B (en) 1998-03-11
HRP950374A2 (en) 1997-10-31
DE19527140A1 (de) 1996-02-01
LT95084A (en) 1996-06-25
ITMI951621A0 (it) 1995-07-26
HU214582B (hu) 1998-04-28
GB9515205D0 (en) 1995-09-20
FR2722988A1 (fr) 1996-02-02
LV11026A (lv) 1996-02-20
IT1277348B1 (it) 1997-11-10
AU2326995A (en) 1996-02-08
AT402690B (de) 1997-07-25
GB2291593A (en) 1996-01-31
BE1011413A4 (fr) 1999-09-07
YU50795A (sh) 1998-05-15

Similar Documents

Publication Publication Date Title
US5047230A (en) Aerosol composition comprising nitroglycerin as active ingredient
EP0673245B1 (fr) Composition pharmaceutique effervescente contenant de l'ibuprofene et son procede de preparation
US5622978A (en) Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form
LV11026B (en) A pharmaceutical composition for lowering the blood pressure and a process for the preparation thereof
EP0190292B1 (de) Pharmazeutische zubereitung
AU765560B2 (en) New process for the purification of aldehyde impurities
LU86484A1 (fr) Sels de furosemide
CA1134820A (en) Triethyl citrate solutions of pge-type compounds
US4143151A (en) Method for treating hyperglycemia in mammals using arylamino benzoic acids
US4402949A (en) Stable solutions of hydrogenated ergotalkaloids
DE69807745T2 (de) Monoargininylsalz der (e)-3-[1-n-butyl-5-[(2-(2-carboxyphenyl)methoxy-4-chlorphenyl]-1h-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl]-prop-2-en carbonsäure
HU179989B (en) Process for preparing pharmacological compositions containing r-/+/-1-/1-phenyl-ethyl/-1h-imidazol-5-carboxylic acid ethyl ester for intravenous administration
DE3429227A1 (de) 1,3-dioxanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4301175A (en) E-Type prostaglandin compositions
IE47791B1 (en) Stable solutions of hydrogenated ergopeptide alkaloids
US6048874A (en) Parenteral metolazone formulations
JP3533228B2 (ja) 低刺激性ニトログリセリン組成物及びスプレー剤
KR19990063822A (ko) 알콕실화 지방의 정제 방법
JPH0283323A (ja) 安定な酪酸リボフラビン水溶液
FR2537435A1 (fr) Nouvelle association medicamenteuse a base d'un alcaloide hydrogene de l'ergot de seigle et d'heparine
US4207330A (en) Method for treating hyperglycemia in mammals using arylamino benzoic acids
HU188202B (en) Process for production of stabilized, injectable medical preparates consisting of - as reagents - 2-(4-)3-/2- chlorine-phentiazine-10-il/-propil)-1-piperazinil/-ethil /3,4,5-trimetoxi/benzoate-diethansulphonate
HU205099B (en) Process for producing new furosemide salts and pharmaceutical compositions comprising same as active ingredient
KR19990064341A (ko) N-(４-옥소-２-(１h-테트라졸-５-일)-４h-１-벤조피란-８-일)-４-(４-페닐부톡시)벤즈아미드의 염
EP0487729A1 (en) Ketotifen preparation for external use